Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
21st Century Medicine has demonstrated successful long-term cryopreservation of complex tissues such as rabbit kidneys and mammalian brains using proprietary vitrification mixtures. Their work has won scientific prizes but their products are currently limited to research applications and are not approved for human medical treatment or diagnosis.
Key achievements include the first successful vitrification, rewarming, and transplantation of a rabbit kidney that functioned post-transplantation, as well as winning both the Small Mammal Brain Preservation Prize (2016) and Large Mammal Brain Preservation Prize (2018).
The company’s solutions enable extended storage times for organs/tissues/cells beyond conventional methods.
They have received NIH funding to study organ preservation solutions.
No clinical trial results exist since they do not develop therapeutics.
Their technologies are used by biopharma companies in preclinical research settings to test drug candidates on preserved tissues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 21st Century Medicine.